Thermo Fisher Scientific | TMO - Cash And Equivalent



Thermo Fisher Scientific reported $4.58B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Agilent USD 1.54B 49M Jul/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Bio Techne USD 162.19M 21.52M Jun/2025
Bio-Rad Laboratories USD 369.3M 152.1M Jun/2025
Boston Scientific USD 725M 311M Mar/2025
Bruker USD 92M 92.2M Jun/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Danaher USD 2.96B 964M Jun/2025
Dentsply International USD 359M 39M Jun/2025
Edwards Lifesciences USD 3.14B 95.4M Mar/2025
Exact Sciences USD 657.1M 650.98M Jun/2025
General Electric Aerospace USD 10.86B 1.54B Jun/2025
Henry Schein USD 145M 18M Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
Illumina USD 934M 179M Jun/2025
Intuitive Surgical USD 9.53B 431.3M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Laboratory Of America USD 647.3M 277.9M Jun/2025
Medtronic USD 2.22B 978M Apr/2025
Mettler Toledo International USD 61.82M 2.47M Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Olympus JPY 241.22B 11.32B Jun/2025
Quest Diagnostics USD 319M 131M Jun/2025
Repligen USD 708.86M 11.63M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Stryker USD 2.38B 55M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Veracyte USD 219.5M 33.38M Jun/2025
Waters USD 367.22M 15.66M Jun/2025
Zimmer Biomet Holdings USD 556.9M 827.6M Jun/2025